Recruiting nowPhase 2Ages 18 Years to 100 Years
Fluorescent Intra-operative Tumor Margin Examination
Sponsor: Kurt Weiss · NCT04719156 on ClinicalTrials.gov ↗
Conditions studied
Sarcoma
What it tests
- Indocyanine green solution administered at 2.0mg/kg.drug
- Stryker SPY-PHI Imaging Devicedevice
Where it's running1 site
- Recruiting now
UPMC-Shadyside Hospital
Pittsburgh, Pennsylvania 15213
- Beata Krawczyk, MS(contact)412-802-4100
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Patients above the age of 18 with a primary musculoskeletal tumor that has been indicated for surgical excision by a fellowship trained orthopaedic oncologist. * Surgical consent was obtained prior to research consent. * Patients with a biopsy-confirmed primary soft tissue or bone tumor that has not been previously excised and has a known risk of local or remote recurrence. Exclusion Criteria: * Patients below the age of 18 * Pregnancy, breast feeding * Patients with a history of anaphylactic reaction to contrast media or fluorescein allergy * Prior surgery local to the mass being excised * Non- or minimally-recurrent masses (i.e. osteochondroma) * Dialysis, renal failure, uremia
Updated 2026-02-20 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.